
A Fond Farewell to Mary Dial
The May 5 Blood & Tissue Center Foundation Board meeting saw a strong turnout of longtime board members eager to celebrate more than 15 years
The May 5 Blood & Tissue Center Foundation Board meeting saw a strong turnout of longtime board members eager to celebrate more than 15 years
New mobile leukapheresis center will help bring lifesaving treatments to a wider patient base SAN ANTONIO, Texas – BBG Advanced Therapies, a subsidiary of San
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
As the sun has set this week, the iconic San Antonio skyline has glowed with vibrant blue and green lights. Five local landmarks have collaborated
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
Originally published as “How To Build Resilience for Advanced Therapies with Supply Chain and Resource Planning”on LinkedIn on March 25, 2025 Blueprint for Breakthroughs is
Donors get a pair of tickets to the State Farm College Slam Dunk Contest, a part of the NCAA’s Final Four weekend. South Texas Blood
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
It was just a regular day for Martha “Marty” Shuh. Another day at Donor Pavilion to donate blood. Marty is a regular, and staff are
A Blueprint for Early-Stage Success Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer